Mutational study of the 1p located genes p18ink4c, Patched-2, RIZ1 and KIF1B in oligodendrogliomas

Oncology Reports

Volumn 13, Issue 3, 2005, Pages 539-542

  Alonso, M Eva ^a   Bello, M Josefa ^a   Arjona, Dolores ^a   Gonzalez Gomez, Pilar ^a   Amiñoso, Cinthia ^a   Lopez Marín, Isabel ^a   De Campos, Jose M ^b   Isla, Alberto ^a   Vaquero, Jesús ^c   Gutierrez, Manuel ^a   Sarasa, Jose L ^d   Rey, Juan A ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^c HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^d Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

Development; KIF1B; Mutation; Oligodendrogliomas; Patched 2; PCR SSCP; RIZ1

Indexed keywords

CDKN2C PROTEIN, HUMAN; CELL CYCLE PROTEIN; CELL SURFACE RECEPTOR; CYCLIN DEPENDENT KINASE INHIBITOR 2C; DNA BINDING PROTEIN; KIF1B PROTEIN, HUMAN; KINESIN; MEMBRANE PROTEIN; NERVE PROTEIN; NUCLEAR PROTEIN; PATCHED RECEPTORS; PRDM2 PROTEIN, HUMAN; PROTEIN KINASE INHIBITOR; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BRAIN TUMOR; CELL TRANSFORMATION; GENETIC POLYMORPHISM; GENETICS; HETEROZYGOSITY LOSS; HUMAN; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIOMA; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM;

BRAIN NEOPLASMS; CELL CYCLE PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASE INHIBITOR P18; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; HUMANS; KINESIN; LOSS OF HETEROZYGOSITY; MEMBRANE PROTEINS; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; OLIGODENDROGLIOMA; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTEIN KINASE INHIBITORS; RECEPTORS, CELL SURFACE; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 15044360022     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.13.3.539     Document Type: Article

References (38)

1. Kleihues P and Cavenee WK: Pathology and genetics of tumors of the nervous system. World Health Organization classification of tumors. IARC Press, Lyon, 2000.
2. Reifenberger J, Reifenberger G, Liu L, James CD, Wechsler W and Collins VP: Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 145: 1175-1190, 1994. (Pubitemid 24345665)
3. Bello MJ, Leone PE, Vaquero J, de Campos JM, Kusak ME, Sarasa JL, Pestaña A and Rey JA: Allelic loss at 1p and 19q frequently occurs in association and may represent early oncogenic events in oligodendroglial tumors. Int J Cancer 64: 207-210, 1995.
4. Zhu JJ, Santarius T, Wu X, Tsong J, Guha A, Wu JK, Hudson TJ and Black PM: Screening for loss of heterozygosity and microsatellite instability in oligodendrogliomas. Genes Chromosomes Cancer 21: 207-216, 1998. (Pubitemid 28136437)
5. Husemann K, Wolter M, Buschges R, Bostrom J, Sabel M and Reifenberger G: Identification of two distinct deleted regions on the short arm of chromosome 1 and rare mutation of the CDKN2C gene from 1p32 in oligodendroglial tumors. J Neuropathol Exp Neurol 58: 1041-1050, 1999. (Pubitemid 29468265)
6. Smith JS, Alderete B, Minn Y, Borell TJ, Perry A, Mohapatra G, et al: Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype. Oncogene 18: 4144-4152, 1999. (Pubitemid 29363922)
7. Felsberg J, Erkwoh A, Sabel MC, et al: Oligodendroglial tumors: Refinement of candidate regions on chromosome arm 1p and correlation of 1p/19q status with survival. Brain Pathol 14: 121-130, 2004. (Pubitemid 38656383)
8. ink4cgene on the short arm of chromosome 1 in anaplastic oligodendrogliomas. Brain Pathol 9: 639-643, 1999.
9. He J, Hoang-Xuan K, Marie Y, Leuraud P, Mokhtari K, Kujas M, Delattre JY and Sanson M: P18 tumor suppressor gene and progression of oligodendrogliomas to anaplasia. Neurology 55: 867-869, 2000.
10. Mai M, Huang H, Reed C, Qian C, Smith JS, Alderete B, Jenkins R, Smith DI and Liu W: Genomic organization and mutation analysis of p73 in oligodendrogliomas with chromosome 1 p-arm deletions. Genomics 51: 359-363, 1998. (Pubitemid 28413202)
11. Bello MJ, de Campos JM, Vaquero J, Ruiz-Barnes P, Kusak ME, Sarasa JL and Rey JA: hRAD54 gene and 1p high-resolution deletion-mapping analyses in oligodendrogliomas. Cancer Genet Cytogenet 116: 142-147, 2000.
12. Alonso ME, Bello MJ, Gonzalez-Gomez P, Lomas J, Arjona D, de Campos JM, Kusak ME, Sarasa JL, Isla A and Rey JA: Mutation analysis of the p73 gene in non-astrocytic brain tumours. Br J Cancer 85: 204-208, 2001. (Pubitemid 32695740)
13. Motoyama J, Takabatake T, Takeshima K and Hui C: Ptch2, a second mouse Patched gene is co-expressed with Sonic hedgehos. Nat Genet 18: 104-106, 1998.
14. Carpenter D, Stone DM, Brush J, Ryan A, Armanini M, Frantz G, Rosenthal A and de Sauvage FJ: Characterization of two patched receptors for the vertebrate hedgehog protein family. Proc Natl Acad Sci USA 95: 13630-13634, 1998. (Pubitemid 28523023)
15. Sasaki O, Meguro K, Tohmiya Y, Funato T, Shibahara S and Sasaki T: Nucleotide alteration of retinoblastoma protein-interacting zinc finger gene, RIZ, in human leukemia. Tohoku J Exp Med 196: 193-201, 2002. (Pubitemid 34727555)
16. He L, Yu JX, Liu L, Buyse IM, Wang MS, Yang QC, et al: RIZ1, but not the alternative RIZ2 product of the same gene, is underexpressed in breast cancer, and forced RIZ1 expression causes G2-M cell cycle arrest and/or apoptosis. Cancer Res 58: 4238-4244, 1998. (Pubitemid 28450017)
17. Jiang G, Liu L, Buyse IM, Simon D and Huang S: Decreased RIZ1 expression, but not RIZ2 in hepatoma and suppression of hepatoma tumorigenicity by RIZ1. Int J Cancer 83: 541-546, 1999. (Pubitemid 29489871)
18. Piao Z, Fang W, Malkhosyan S, Kim H, Horii A, Perucho M and Huang S: Frequent frameshift mutations of RIZ in sporadic gastrointestinal and endometrial carcinomas with microsatellite instability. Cancer Res 60: 4701-4704, 2000.
19. Zhao C, Takita J, Tanaka Y, Setou M, Nakagawa T, et al: Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1B beta. Cell 105: 587-597, 2001. (Pubitemid 32524112)
20. Chen YY, Takita J, Chen YZ, Yang HW, Hanada R, Yamamoto K and Hayashi Y: Genomic structure and mutational analysis of the human KIF1B alpha gene located at 1p36.2 in neuroblastoma. Int J Oncol 23: 737-744, 2003.
21. Yang HW, Chen YZ, Takita J, Soeda E, Piao HY and Hayashi Y: Genomic structure and mutational analysis of the human KIF1B gene which is homozygously deleted in neuroblastoma at chromosome 1p36.2. Oncogene 20: 5075-5083, 2000. (Pubitemid 32769799)
22. Alonso ME, Bello MJ, Gonzalez-Gomez P, Arjona D, Lomas J, de Campos JM, Isla A, Sarasa JL and Rey JA: Aberrant promoter methylation of multiple genes in oligodendrogliomas and ependymomas. Cancer Genet Cytogenet 144: 134-142, 2003. (Pubitemid 36808960)
23. Rey JA, Bello MJ, Jimenez-Lara A, Vaquero J, Kusak ME, de Campos JM, Sarasa JL and Pestaña A: Loss of herterozygosity for distal markers on 22q in human gliomas. Int J Cancer 51: 703-706, 1992.
24. Smyth I, Narang MA, Evans T, Heimann C, Nakamura Y, Chenevix-Trench G, Pietsch T, Wicking C and Wainwright BJ: Isolation and characterization of human patched 2 (PTCH2), a putative tumour suppressor gene in basal cell carcinoma and medulloblastoma on chromosome 1p32. Hum Mol Genet 8: 291-297, 1999. (Pubitemid 29054270)
25. Fang W, Piao Z, Simon D, Sheu JC and Huang S: Mapping of a minimal deleted region in human hepatocellular carcinoma to 1p36.13-p36.23 and mutational analysis of the RIZ (PRDM2) gene localized to the region. Genes Chromosomes Cancer 28: 269-275, 2000. (Pubitemid 30399556)
26. Mitelman F, Mertens F and Johansson B: A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet 15: 417-474, 1997.
27. Bello MJ, Leone PE, Nebreda P, de Campos JM, Kusak ME, et al: Allelic status of chromosome 1 in neoplasms of the nervous system. Cancer Genet Cytogenet 83: 160-164, 1995.
28. INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev 8: 2939-2952, 1994.
29. Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR, Silver JS, Stark PC, Macdonald DR, Ino Y, Ramsay DA and Louis DN: Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90: 1473-1479, 1998. (Pubitemid 28482012)
30. Wolter M, Reifenberger J, Sommer C, Ruzicka T and Reifenberger G: Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res 57: 2581-2585, 1997. (Pubitemid 27283761)
31. Gailani MR, Stahle-Backdahl M, Leffell DJ, Glynn M, Zaphiropoulos PG, Pressman C, Unden AB, Dean M, Brash DE, Bale AE and Toftgard R: The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nat Genet 14: 78-81, 1996. (Pubitemid 26301550)
32. Wicking C, Shanley S, Smyth I, Gillies S, Negus K, Graham S, Suthers G, Haites N, Edwards M, Chenevix-Trench G and Wainwright B: Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the PATCHED protein, and no genotype-phenotype correlations are evident. Am J Hum Genet 60: 21-26, 1997. (Pubitemid 26427774)
33. Jogi A, Abel F, Sjoberg RM, Toftgard R, Zaphiropoulos PG, Pahlman S, Martinsson T and Axelson H: Patched 2, located in 1p32-34, is not mutated in high stage neuroblastoma tumors. Int J Oncol 16: 943-949,2000.
34. Carling T, Du Y, Fang W, Correa P and Huang S: Intragenic allelic loss and promoter hypermethylation of the RIZ1 tumor suppressor gene in parathyroid tumors and pheochromocytomas. Surgery 134: 932-939, 2003.
35. Dracopoli NC, Harnett P, Bale SJ, Stanger BZ, Tucker MA, Housman DE and Kefford RF: Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression. Proc Natl Acad Sci USA 86: 4614-4618, 1989. (Pubitemid 19164600)
36. Poetsch M, Dittberner T, Woenckhaus C: Frameshift mutations of RIZ, but no point mutations in RIZ1 exons in malignant melanomas with deletions in lp36. Oncogene 21: 3038-3042, 2002. (Pubitemid 34522903)
37. Chadwick RB, Jiang GL, Bennington GA, Yuan B, Johnson CK, Stevens MW, Niemann TH, Peltomaki P, de la Chapelle A and Huang S: Candidate tumor suppressor RIZ is frequently involved in colorectal carcinogenesis. Proc Natl Acad Sci USA 97: 2662-2667, 2000. (Pubitemid 30159228)
38. Schwab M, Praml C and Amler LC: Genomic instability in 1p and human malignancies. Genes Chromosomes Cancer 16: 211-229, 1996. (Pubitemid 26299976)